No Data
No Data
Leading Brokers Name 3 ASX Shares to Buy Today 28 April 2025
What Does Macquarie Think ResMed Shares Are Worth?
ResMed's Tariff Exemption Should Support Multiples -- Market Talk
Morgans Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
ResMed Price Target Cut 1.6% to A$48.00/Share by Macquarie
ResMed Inc. Files Quarterly Report, Reinforces Market Position
PAUL BIN ANTHONY : good luck